Cite
HARVARD Citation
Chin-Yee, D. et al. (2016). A systematic review of as needed versus treat and extend ranibizumab or bevacizumab treatment regimens for neovascular age-related macular degeneration. British journal of ophthalmology. 100 (7), pp. 914-917. [Online].